Peterson; Emily Anne
Patent Applications and Registrations
Patent applications and USPTO patent grants for Peterson; Emily Anne.The latest application filed is for "imidazo[1,2-a]pyridinyl derivatives as irak4 inhibitors".
- Peterson; Emily Anne - Belmont MA
- Peterson; Emily Anne - Cambridge MA
- Peterson; Emily Anne - Garobridge MA
| Patent | Date |
|---|---|
| Imidazo[1,2-a]pyridinyl Derivatives As Irak4 Inhibitors App 20220089592 - Hopkins; Brian T. ; et al. | 2022-03-24 |
| Bicyclic sulfonamide compounds as sodium channel inhibitors Grant 9,776,995 - Weiss , et al. October 3, 2 | 2017-10-03 |
| Bicyclic sulfonamide compounds as sodium channel inhibitors Grant 9,458,152 - Weiss , et al. October 4, 2 | 2016-10-04 |
| Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors Grant 9,346,798 - Boezio , et al. May 24, 2 | 2016-05-24 |
| Bicyclic Sulfonamide Compounds as Sodium Channel Inhibitors App 20160137636 - WEISS; Matthew ; et al. | 2016-05-19 |
| Bicyclic Sulfonamide Compounds As Sodium Channel Inhibitors App 20160046626 - WEISS; Matthew ; et al. | 2016-02-18 |
| Bicyclic aryl and heteroaryl sodium channel inhibitors Grant 9,012,443 - Boezio , et al. April 21, 2 | 2015-04-21 |
| Dihydrobenzoxazine And Tetrahydroquinoxaline Sodium Channel Inhibitors App 20150057271 - Boezio; Christiane ; et al. | 2015-02-26 |
| Bicyclic Aryl and Heteroaryl Sodium Channel Inhibitors App 20130150339 - BOEZIO; Christiane ; et al. | 2013-06-13 |
| Heteroaryl Compounds as PIKK Inhibitors App 20120190666 - Bode; Christiane ; et al. | 2012-07-26 |
| Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors App 20120165334 - Boezio; Alessandro ; et al. | 2012-06-28 |
| Imidazopyridazine inhibitors of PI3 kinase for cancer treatment Grant 7,820,665 - Booker , et al. October 26, 2 | 2010-10-26 |
| Inhibitors of PI3 kinase App 20090163489 - Booker; Shon ; et al. | 2009-06-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 